Maraviroc Attenuates Trauma-Hemorrhage-Induced Hepatic Injury through PPAR Gamma-Dependent Pathway in Rats

Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model

(2013) Laura Ochoa-Callejero et al.   PLoS One

Osthole Attenuates Hepatic Injury in a Rodent Model of Trauma-Hemorrhage

(2013) Huang-Ping Yu et al.   PLoS One

Endothelial Cell Peroxisome Proliferator-Activated Receptor   Reduces Endotoxemic Pulmonary Inflammation and Injury

(2012) A. T. Reddy et al.   JOURNAL OF IMMUNOLOGY

The effects of PPAR-γ agonist pioglitazone on renal ischemia/reperfusion injury in rats

(2012) Buket Reel et al.   JOURNAL OF SURGICAL RESEARCH

Decreased pain responses of C–C chemokine receptor 5 knockout mice to chemical or inflammatory stimuli

(2012) Yong Kyoung Lee et al.   NEUROPHARMACOLOGY

Protective Effect of Tropisetron on Rodent Hepatic Injury after Trauma-Hemorrhagic Shock through P38 MAPK-Dependent Hemeoxygenase-1 Expression

(2012) Fu-Chao Liu et al.   PLoS One

In vitro effect of anti-human immunodeficiency virus CCR5 antagonist maraviroc on chemotactic activity of monocytes, macrophages and dendritic cells

(2011) R. Rossi et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

2-(2-Fluorobenzamido)benzoate ethyl ester (EFB-1) inhibits superoxide production by human neutrophils and attenuates hemorrhagic shock-induced organ dysfunction in rats

(2011) Huang-Ping Yu et al.   FREE RADICAL BIOLOGY AND MEDICINE

CCR5 Blockade in Combination with Cyclosporine Increased Cardiac Graft Survival and Generated Alternatively Activated Macrophages in Primates

(2011) J. Li et al.   JOURNAL OF IMMUNOLOGY

Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120

(2011) Lucia Lisi et al.   JOURNAL OF NEUROCHEMISTRY

Mechanism of Salutary Effects of Astringinin on Rodent Hepatic Injury following Trauma-Hemorrhage: Akt-Dependent Hemeoxygenase-1 Signaling Pathways

(2011) Fu-Chao Liu et al.   PLoS One

Maraviroc

(2010) Caroline M. Perry   DRUGS

Treatment of HIV infection with the CCR5 antagonist maraviroc

(2010) Wiete Kromdijk et al.   EXPERT OPINION ON PHARMACOTHERAPY

Role of PPARγ in the salutary effects of 17β-estradiol on kupffer cell cytokine production following trauma-hemorrhage

(2010) Takao Suzuki et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Role of Akt-dependent up-regulation of hemeoxygenase-1 in resveratrol-mediated attenuation of hepatic injury after trauma hemorrhage

(2010) Huang-Ping Yu et al.   SURGERY

Lung injury after hemorrhage is age dependent: Role of peroxisome proliferator-activated receptor γ*

(2009) Basilia Zingarelli et al.   CRITICAL CARE MEDICINE

Male Gender is Associated With Excessive IL-6 Expression Following Severe Injury

(2009) Jason L. Sperry et al.   JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE

PPARγ agonist rosiglitazone is neuroprotective after traumatic brain injury via anti-inflammatory and anti-oxidative mechanisms

(2008) Jae-Hyuk Yi et al.   BRAIN RESEARCH

Peroxisome proliferator activated receptor γ agonists suppress TNFα-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species

(2008) Yuyeon Jung et al.   IMMUNOLOGY LETTERS

Amelioration of pulmonary dysfunction and neutrophilic inflammation by PPARγ agonist in LPS-exposed guinea pigs

(2008) Rohini Sharma et al.   PULMONARY PHARMACOLOGY & THERAPEUTICS